The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Bristol-Myers Squibb Co

NYSE: BMY
Last

(U.S.) $57.67

Today's change0.00 0.00%
Updated August 22 4:00 PM EDT. Delayed by at least 15 minutes.
 

Bristol-Myers Squibb Co

NYSE: BMY
Last

(U.S.) $57.67

Today's change0.00 0.00%
Updated August 22 4:00 PM EDT. Delayed by at least 15 minutes.

Bristol-Myers Squibb Co closed at (U.S.)$57.67.

Shares have lost 0.35% over the last five days, but are unchanged over the last year to date. This security has underperformed the S&P 500 by 15.05% during the last year.

Key company metrics

  • Open(U.S.) $56.79
  • Previous close(U.S.) $57.67
  • High(U.S.) $57.80
  • Low(U.S.) $56.65
  • Bid / Ask-- / --
  • YTD % change-1.32%
  • Volume4,441,031
  • Average volume (10-day)5,696,445
  • Average volume (1-month)6,643,048
  • Average volume (3-month)7,473,668
  • 52-week range(U.S.) $46.01 to (U.S.) $60.45
  • Beta1.18
  • Trailing P/E21.02×
  • P/E 1 year forward19.38×
  • Forward PEG2.31×
  • Indicated annual dividend(U.S.) $1.56
  • Dividend yield2.71%
  • Trailing EPS(U.S.) $2.74
Updated August 22 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.22%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue5,1444,9295,2434,922
Total other revenue--------
Total revenue5,1444,9295,2434,922
Gross profit3,7123,6703,8663,624
Total cost of revenue1,4321,2591,3771,298
Total operating expense3,8092,9684,1153,369
Selling / general / administrative1,1671,0741,4611,144
Research & development1,1701,0911,3871,138
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)725-25730-53
Other operating expenses, total-685-199-140-158
Operating income1,3351,9611,1281,553
Interest income (expense), net non-operating-52-45-40-42
Gain (loss) on sale of assets--------
Other--------
Income before tax1,2951,9551,0861,559
Income after tax9221,5268981,215
Income tax, total373429188344
Net income9161,5748941,202
Total adjustments to net income--------
Net income before extra. items9161,5748941,202
Minority interest-648-4-13
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items9161,5748941,202
Inc. avail. to common incl. extra. items9161,5748941,202
Diluted net income9161,5748941,202
Dilution adjustment--------
Diluted weighted average shares1,6501,6711,6831,679
Diluted EPS excluding extraordinary itemsvalue per share0.560.940.530.72
Dividends per sharevalue per share0.390.390.380.38
Diluted normalized EPSvalue per share0.870.820.550.69